𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Improved survival after neoadjuvent carboplatin/5 FU in resectable stage II and III squamous cell carcinomas of the oral cavity and the tonsil

✍ Scribed by Schröder, M.; Müller, R.-P.; Knüfermann, H; Volling, P.

Book ID
121993838
Publisher
Elsevier Science
Year
1993
Tongue
English
Weight
169 KB
Volume
29
Category
Article
ISSN
0959-8049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Improved survival with perilymphatic int
Improved survival with perilymphatic interleukin 2 in patients with resectable squamous cell carcinoma of the oral cavity and oropharynx
✍ Antonella De Stefani; Guido Forni; Riccardo Ragona; Giovanni Cavallo; Mario Buss 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 344 KB 👁 1 views

## Abstract ## BACKGROUND The current randomized, multicenter, Phase III trial was conducted to determine whether the disease free interval and overall survival of patients with T2–T4,N0–N3,M0 squamous cell carcinoma (SCC) of the oral cavity or oropharynx could be extended through the combination

Survival in squamous cell carcinoma of t
Survival in squamous cell carcinoma of the oral cavity : Differences between pT4 N0 and other stage IVA categories
✍ Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 103 KB 👁 1 views

## Abstract ## BACKGROUND. According to the American Joint Commission on Cancer (AJCC, 5^th^ edition) classification system, pT4 N0 oral cavity squamous cell carcinoma (OSCC) qualifies for stage IVA status, with its implied poor prognosis. However, preliminary observations suggested that patients